InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
4
T+90 hit rate
50%
T+90 mean return
-4.8%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Foley Mark J, Director. Director active across 3 companies, notably GLAUKOS Corp. In total, 40 reports have been published. Split: 3 buys · 4 sells. Total volume traded: €2.5m. Activity tracked since 3 June 2021. The latest transaction was filed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations40 total
1,878 shares0Common StockSEC:0001529196-26-000004:0
25,000 shares@ US$32.0091.9% of flowCommon StockSEC:0001415889-25-006046:0
996,935 shares@ US$3.6537.5% of flowCommon StockSEC:0000950170-25-015363:0
27,933 shares0Common StockSEC:0000950170-25-014825:0
1,000 shares@ US$2.18450.0% of flowCommon StockSEC:0001479290-25-000004:0
1,000 shares@ US$2.18450.0% of flowCommon StockSEC:0001479290-24-000104:0
1,716 shares0Common StockSEC:0001415889-24-015236:0
3,305 shares@ US$5.3050.2% of flowCommon StockSEC:0001479290-24-000065:0
30,000 shares@ US$6.982.1% of flowCommon StockSEC:0001479290-24-000056:0
Ideal exit: 1 Dec 2024 (T+270)
70,750 shares0Common StockSEC:0001479290-24-000050:0
10,000 shares@ US$7.2758.1% of flowCommon StockSEC:0001415889-24-005327:0
264 shares@ US$7.470.0% of flowCommon StockSEC:0001479290-24-000004:0
122,143 shares0Common StockSEC:0001479290-23-000096:0
26,279 shares@ US$22.57135.8% of flowCommon StockSEC:0001479290-23-000084:0
1,000 shares@ US$15.6060.2% of flowCommon StockSEC:0001479290-23-000081:0
31,279 shares@ US$30.72129.5% of flowCommon StockSEC:0001479290-23-000078:0
3,230 shares0Common StockSEC:0001415889-23-009293:0
175,649 shares0Common StockSEC:0001479290-23-000074:0
5,341 shares@ US$30.651.6% of flowCommon StockSEC:0001479290-23-000042:0
175,649 shares0Common StockSEC:0001479290-23-000034:0
2,948 shares0Common StockSEC:0001415889-23-000386:0
605 shares@ US$12.18050.1% of flowCommon StockSEC:0001479290-23-000001:0
49,274 shares@ US$26.9714.5% of flowCommon StockSEC:0001479290-22-000087:0
1,000 shares@ US$11.7470.1% of flowCommon StockSEC:0001479290-22-000074:0
4,364 shares0Common StockSEC:0001104659-22-068667:0
25 of 40 declarations
About Foley Mark J
Mark J. Foley is a Board Member and President & CEO at GLAUKOS Corp and Revance Therapeutics, Inc. He oversees the operations and strategy of these companies. Foley is recognized for his expertise in health and biotechnology.
